Biotech | February 17, 2022
Pebble engages MD Anderson to evaluate multi-cannabinoid formulations in ovarian cancer
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Domestic business was up 41.9% YoY and 27.7% QoQ
The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
